Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015

by GBD 2015 Tobacco Collaborators
The Lancet, Vol. 389, No. 10082, pp.1885–1906, 13 May 2017

22 pp. 19.7 MB(!)

The scale-up of tobacco control, especially after the adoption of the Framework Convention for Tobacco Control, is a major public health success story. Nonetheless, smoking remains a leading risk for early death and disability worldwide, and therefore continues to require sustained political commitment. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) offers a robust platform through which global, regional, and national progress toward achieving smoking-related targets can be assessed.

(Visited 27 times, 1 visits today)
This entry was posted in General, Global Health, Non-communicable Diseases. Bookmark the permalink.